Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange

Contributed by: PR Newswire

Tags

QimingVenturePartners

More Like This

China's Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock Exchange

Leading Chinese Innovative Medical Device Maker Insight Lifetech Has Successfully Listed on STAR Market

PR Newswire associated0

Ribo Announces Strategic Collaboration with Insilico Medicine to Accelerate siRNA Drug Development Driven by AI

China's AGI Pioneer and Leader Z.ai Listed on Hong Kong Stock Exchange

PR Newswire associated0

Ribo Life Science (06938.HK) Successfully Lists on the Main Board of the Hong Kong Stock Exchange

Qiming Venture Partners' Portfolio Company Yunji Technology Successfully Lists on the Hong Kong Stock Exchange

PR Newswire associated0

Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology

Qiming Venture Partners Managing Partner Alex Zhou Named to 2026 Forbes Midas List